Iki S, Urabe A
Division of Hematology, NTT Kanto Medical Center, Tokyo, Japan.
Gan To Kagaku Ryoho. 2000 Oct;27(11):1635-40.
Management of the side effects of chemotherapy in cancer patients is important because side effects can affect the tolerability and continuation of therapy, in addition to lowering the quality of life of patients. A significant efficacy of serotonin receptor antagonists against nausea and vomiting due to cancer chemotherapy, and granulocyte colony-stimulating factor against neutropenia secondary to chemotherapy, has been recently demonstrated. New chemoprotective drugs have been developed, such as amifostine for cisplatin-induced nephrotoxicity and neurotoxicity, and dexrazoxane for cardiac toxicity due to anthracyclines. Antiviral agents including lamivudine and interferons suppress virus replication, preventing the development of fulminant hepatitis during chemotherapy in cancer patients who have chronic hepatitis B infection. Various supportive therapies have resulted in the advance of cancer chemotherapy.
癌症患者化疗副作用的管理很重要,因为副作用不仅会降低患者的生活质量,还会影响治疗的耐受性和持续性。最近已证实,5-羟色胺受体拮抗剂对癌症化疗引起的恶心和呕吐具有显著疗效,粒细胞集落刺激因子对化疗继发的中性粒细胞减少也有显著疗效。已研发出新型化学保护药物,如用于预防顺铂引起的肾毒性和神经毒性的氨磷汀,以及用于预防蒽环类药物引起的心脏毒性的右丙亚胺。包括拉米夫定和干扰素在内的抗病毒药物可抑制病毒复制,从而防止慢性乙型肝炎感染的癌症患者在化疗期间发生暴发性肝炎。各种支持疗法推动了癌症化疗的发展。